OMEPRAZOLE EXTENDED-RELEASE CAPSULES
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F7351 for the delivery of OMEPRAZOLE EXTENDED-RELEASE CAPSULES, identified by NSN 6505016247068 and PR 7017471541. The total contract value is $203.20, with an award date of July 11, 2026, and the order is placed under the underlying contract SPE2DX25D9900. The awardee, identified by CAGE code 1UNB0, is a federal supplier providing pharmaceutical products to the Department of Defense. The contract details indicate no set-aside classification or NAICS code has been assigned, and the point of contact and performance location information are unspecified. All documentation and ordering details are accessible through the DIBBS portal using the provided UI link.
General Info
Agency
Contract Value
$203.2NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
